Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. (NY: SNY )

43.41 USD UNCHANGED
Last Price Updated: 5:16 PM EST, Dec 31, 2018 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 43.41
Bid (Size) 43.00 (2)
Ask (Size) 45.15 (2)
Prev. Close 43.41
Today's Range 43.41 - 43.41
52wk Range N/A - N/A
Shares Outstanding 2,478,367,994
Dividend Yield 4.29%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Promising Oncology Breakthroughs Sparking Wave of Next Generation of Brain Cancer Therapies
FN Media Group Presents USA News Group News Commentary 
From PR Newswire

Performance

More News

Read More
Sanofi/Regeneron's DUPIXENT Wins Canada Approval For Atopic Dermatitis In Children Aged 6-11
Tags Market News Biotech FDA
From Benzinga
FDA Approves Regeneron/Sanofi's Libtayo For Front-Line Lung Cancer
Tags Benzinga Market News REGN
From Benzinga
FDA Says Conduct Smaller Trials To Test Vaccine Efficacy Against COVID Variants
Tags SNY Health Care FDA
From Benzinga
Pandion Therapeutics Surges To Record High On Merck's $1.85 Billion Buyout
From Investor's Business Daily
Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg
Tags Biotech BMY Health Care
From Benzinga
3 Green Flags for Novavax Investors, and 1 Red Flag
Tags Market News SNY MRNA
From Motley Fool
Sanofi Offers Cash Buyout For Kiadis
Tags M&A Market News Benzinga
From Benzinga
The Week Ahead In Biotech: FDA Decision On G1 Therapeutics, Earnings In The Mix For Light Calendar Week
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Sanofi/Regeneron's Libtayo Wins FDA Approval For A Type Of Skin Cancer
Tags REGN General FDA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]